ARTICLE | Company News

MegaPharm, Vanda sales and marketing update

December 19, 2011 8:00 AM UTC

Vanda granted Megapharm exclusive commercialization rights to schizophrenia drug Fanapt iloperidone in Israel. Vanda said a regulatory application was filed in Israel in May. Vanda will supply the serotonin (5-HT2) receptor and dopamine receptor antagonist to Megapharm. Terms were not disclosed. ...